Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)

Author:

Shi Yuankai1ORCID,Wu Lin2ORCID,Yu Xinmin3,Xing Puyuan1,Wang Yan1,Zhou Jianying4,Wang Airong5,Shi Jianhua6,Hu Yi7,Wang Ziping8,An Guangyu9,Fang Yong10,Sun Sanyuan11,Zhou Caicun12ORCID,Wang Changli13,Ye Feng14,Li Xingya15,Wang Junye16,Wang Mengzhao17ORCID,Liu Yunpeng18,Zhao Yanqiu19,Yuan Ying20,Feng Jifeng21,Chen Zhendong22,Shi Jindong23,Sun Tao24,Wu Gang25,Shu Yongqian26ORCID,Guo Qisen27,Zhang Yi28,Song Yong29,Zhang Shucai30,Chen Yuan31,Li Wei32,Niu Hongrui33,Hu Wenwei34,Wang Lijun35,Huang Jianan36,Zhang Yang37,Cheng Ying38,Wu Zhengdong39,Peng Bo40,Sun Jiya40,Mancao Christoph40,Wang Yanqi41,Sun Luyao41

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs Beijing P. R. China

2. Department II of Thoracic Medicine Hunan Cancer Hospital Changsha Hunan P. R. China

3. Department of Medical Oncology Zhejiang Cancer Hospital Hangzhou Zhejiang P. R. China

4. Department of Respiratory Diseases, The First Affiliated Hospital, College of Medicine Zhejiang University Hangzhou Zhejiang P. R. China

5. The Third Department of Chemotherapy Weihai Municipal Hospital Weihai Shandong P. R. China

6. Department of Medical Oncology Linyi Cancer Hospital Linyi Shandong P. R. China

7. Oncology Department General Hospital of Chinese People's Liberation Army Beijing P. R. China

8. Department of Chest Medicine Beijing Cancer Hospital Beijing P. R. China

9. Department of Oncology Beijing Chao‐Yang HospitalCapital Medical University Beijing P. R. China

10. Department of Medical Oncology Sir Run Run Shaw Hospital, Zhejiang University Hangzhou Zhejiang P. R. China

11. Department of Medical Oncology Xuzhou Central Hospital Xuzhou Medical University Xuzhou Jiangsu P. R. China

12. Department of Medical Oncology Shanghai Pulmonary Hospital, Tongji University Shanghai P. R. China

13. Department of Lung Cancer Tianjin Medical University Cancer Institute and Hospital Tianjin P. R. China

14. Department of Medical Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, The Third Clinical Medical College Fujian Medical University Xiamen Fujian P. R. China

15. Department of Medical Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan P. R. China

16. Department of Oncology Affiliated Hospital of Jining Medical University Jining Shandong P. R. China

17. Department of Respiratory and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing P. R. China

18. Department of Medical OncologyKey Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province The First Hospital of China Medical University Shenyang Liaoning P. R. China

19. Department of Internal Medicine Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University Zhengzhou Henan P. R. China

20. Department of Medical Oncology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang P. R. China

21. Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiangsu P. R. China

22. Department of Oncology The Second Hospital of Anhui Medical University Hefei Anhui P. R. China

23. Department of Respiratory Medicine Shanghai Fifth’ People's HospitalFudan University Shanghai P. R. China

24. Department of Medical Oncology Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute Shenyang Liaoning P. R. China

25. Cancer Center, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei P. R. China

26. Department of Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu P. R. China

27. Department of Oncology Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute Jinan Shandong P. R. China

28. Department of Thoracic Surgery Xuanwu Hospital Capital Medical University Beijing P. R. China

29. Department of Respiratory and Critical Care Medicine The General Hospital of the Eastern Theater Command of PLA Nanjing Jiangsu P. R. China

30. Department of Oncology, Beijing Chest Hospital, Capital Medical University Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing P. R. China

31. Department of Oncology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei P. R. China

32. Cancer Center The First Hospital of Jilin University Changchun Jilin P. R. China

33. Department of Oncology The First Affiliated Hospital of Xinxiang Medical University Xinxiang Henan P. R. China

34. Department of Oncology The First People's Hospital of Changzhou Changzhou Jiangsu P. R. China

35. Department of Tumor Radiotherapy The Second Affiliated Hospital of Xingtai Medical College Xingtai Hebei P. R. China

36. Department of Respiratory Medicine The First Affiliated Hospital of Soochow University Suzhou Jiangsu P. R. China

37. Department of Oncology The Second Hospital of Dalian Medical University Dalian Liaoning P. R. China

38. Department of Thoracic Oncology Jilin Cancer Hospital Changchun Jilin P. R. China

39. Department of Oncology Jiangsu Taizhou People's Hospital Taizhou Jiangsu P. R. China

40. New Drug Biology and Translational Medicine Innovent Biologics, Inc. Suzhou Jiangsu P. R. China

41. Medical Science and Strategy Oncology Innovent Biologics, Inc. Suzhou Jiangsu P. R. China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3